|
|
|
|
Vol. 63, Issue 2, 332-341, February 2003
4
2 Nicotinic Acetylcholine
Receptors
Department of Neuroscience, University of Pennsylvania Medical School, Philadelphia, Pennsylvania
| |
Abstract |
|---|
|
|
|---|
Two functional types of nicotinic acetylcholine receptors
(nAChRs) are expressed when human embryonic kidney cells are
permanently transfected with equal amounts of human
4 and
2
subunit cDNAs. Most (82%) of these nAChRs exhibit an EC50
of 74 ± 6 µM for ACh, a much lower sensitivity than the
remaining fraction (EC50 of 0.7 ± 0.4 µM) or than
expected from expression of equal amounts of
4 and
2 mRNAs in
Xenopus laevis oocytes. We have found three conditions
that can increase the number of nAChRs with high sensitivity to
activation. These are: 1) transient transfection with additional
2
subunits, 2) overnight incubation in nicotine, or 3) overnight culture
at 29°C. Using metabolic labeling with [35S]methionine
to measure subunit stoichiometry, we found that the majority of nAChRs
had a stoichiometry of (
4)3(
2)2.
Overnight treatment with nicotine increased the number of nAChRs and
increased the proportion of the (
4)2(
2)3
stoichiometry. Alternate
4
2 nAChR stoichiometries with distinct
functional properties raise the possibility for an interesting mode of
synaptic regulation for nicotinic signaling in the mammalian brain.
| |
Introduction |
|---|
|
|
|---|
The
4
2 nAChR is the predominant nAChR subtype in the mammalian brain
that has high affinity for nicotine. nAChRs composed of
4 and
2
subunits modulate neurotransmitter release (Dani, 2001
) and play a
direct role in addiction to nicotine (Picciotto et al., 1998
; Marubio
et al., 1999
). Mutations in
4
2 nAChRs have been linked to
autosomal-dominant nocturnal frontal lobe epilepsy (Weiland et al.,
2000
). They also are thought to be involved in Alzheimer's and
Parkinson's diseases (Rusted et al., 2000
).
Two different approaches showed independently that chick
4
2
nAChRs have a stoichiometry of
(
4)2(
2)3 when
expressed in Xenopus laevis oocytes from cRNAs or cDNAs
injected at a 1:1 (
/
) ratio (Anand et al., 1991
; Cooper et al.,
1991
). A more recent study showed that when the rat
4/
2 subunit
ratio is varied, nAChRs of two functional classes are formed in oocytes
(Zwart and Vijverberg, 1998
). When the
4/
2 ratio was 1:9, nAChRs
were formed that were more sensitive to activation and desensitized more slowly. However, when the ratios were 1:1 or 9:1, nAChRs appeared
that were less sensitive to activation and desensitized more rapidly.
These findings raised the possibility that
4
2 nAChRs can also
exist in a stoichiometry that differs from
(
4)2(
2)3.
Here, we report that the majority (82%) of
4
2 nAChRs expressed
in a stable HEK cell line exhibit sensitivity to activation by ACh that
is much lower (EC50 = 74 ± 6 µM) than
when
4
2 nAChRs are expressed in Xenopus laevis oocytes
[EC50 = 2.2 ± 0.1 µM (Kuryatov et al.,
1997
)]. This confirms the observations by Buisson and Bertrand (2001)
in another independently derived line. They also reported that nicotine
and other nicotinic agents increased the proportion of high-sensitivity
nAChRs and speculated that the increase was caused by slow conversion
of existing low-sensitivity nAChRs to high-sensitivity nAChRs. However,
it is well known that nicotine, other nicotinic agonists, and some
nicotinic antagonists cause an increase in both total and surface
nAChRs (Benwell et al., 1988
; Wonnacott, 1990
; Marks et al., 1992
; Peng
et al., 1994
; Gopalakrishnan et al., 1996
; Whiteaker et al., 1998
).
Also, the properties of the low-sensitivity nAChRs are very much like
those reported by Zwart and Vijverberg (1998)
when nAChRs are formed from an
4:
2 ratio of 9:1. Consistent with the hypothesis that our
4
2 cell line might express high
4/
2 subunit ratio nAChRs, we found that boosting
2 subunit levels by transient transfection with additional
2 cDNA increased the number of more sensitive nAChRs. A similar effect was found for incubation in nicotine and by
culturing at 29°C. Most significantly, we show, using metabolic labeling with [35S]methionine, that the
majority of nAChRs produced by our cell line have a stoichiometry of
(
4)3(
2)2.
Long-term exposure to nicotine resulted in a large increase in
assembled nAChRs accompanied by an increase in the proportion of those
having greater sensitivity to activation and a stoichiometry of
(
4)2(
2)3. We
speculate that two
4
2 stoichiometries exist in mammalian brain.
Functional studies with mouse thalamic synaptosomes support this
hypothesis because they reveal the existence of equal proportions of
low- and high-sensitivity
4
2 nAChRs (Marks et al., 1999
; Butt et al., 2002
). Only
4 and
2 subunits were detected in significant numbers in thalamus by in situ hybridization, and knockout of either
subunit eliminated essentially all binding of epibatidine in this area
(Picciotto et al., 2001
). The thalamus is the largest contiguous area
of
4
2 nAChR expression in rodent brain. Therefore, a strong case
can be made for a functional role for each of the two
4
2 nAChRs
stoichiometries in mammalian brain. The shift in assembly toward the
(
4)2(
2)3 form caused
by long-term nicotine exposure could be important in understanding
nicotine addiction.
| |
Materials and Methods |
|---|
|
|
|---|
Cloning and Tissue Culture.
The details of the cloning of
the stably transfected cell line expressing the human
4
2 nAChR
will be described elsewhere (A. Kuryatov and J. Lindstrom, in
preparation). Briefly, human
4 cDNA in the pcDNA3.1/Zeo(+)
vector (Invitrogen, Carlsbad, CA) and human
2 cDNA in the pRc/CMV
vector (Invitrogen), in equal amounts, were transfected into human
embryonic kidney (HEK) tsA201 cells using Fugene 6 (Roche Diagnostics,
Indianapolis, IN) transfection reagent. Cloning rings were used to
isolate individual clones that were subsequently screened for high,
stable expression by radioimmune assays using
[3H]epibatidine binding to nAChRs isolated from
Triton X-100 cell extracts on mAb 295-coated Immulon 4 microwells
(Dynatech Laboratories, Chantilly, VA). Transfected cells were
maintained in Dulbecco's modified Eagle's medium (DMEM) with
penicillin (100 U/ml), streptomycin (100 µg/ml) (Invitrogen), and
10% fetal bovine serum (Hyclone, Logan, UT) as described previously
(Wang et al., 1998
). Zeocin (0.5 mg/ml; Invitrogen) was used for
selection of
4 expression, and G-418 (0.6 mg/ml; Invitrogen) was
used for selection of
2 subunit expression. For some experiments,
cells were transiently transfected with additional
2 or
4 subunit
cDNA by mixing 1 µg of DNA in a 1:6 ratio (w/v) with Fugene 6, per
the manufacturer's directions, 1 day after plating in 35-mm plastic
tissue culture dishes that contained five glass coverslips (12-mm diameter).
Whole-Cell Electrophysiology.
At least 2 days before
recording, HEK cells were plated onto glass coverslips coated with rat
tail collagen (type 1; Collaborative Biomedical Products, Bedford, MA).
Agonist-containing solutions were applied to the cells by gravity
through fused glass tubing that was connected to multiple reservoirs
mounted above the recording chamber. The recording solution contained
150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM
CaCl2, and 5 mM HEPES and was adjusted to pH 7.3 with NaOH. Electrodes (5-8 M
) were formed from borosilicate glass
and were filled with a solution containing 150 mM Cs-gluconate, 10 mM
Cs-EGTA, and 10 mM HEPES and was adjusted to pH 7.2 with CsOH. Currents
were acquired and analyzed as described previously (Nelson et al.,
2001
). Currents for each cell were normalized to the response of that
cell to the application of 300 µM ACh. Concentration-response curves
were constructed and fitted to the following equation in Origin (Ver.
4.1; Microcal Software, Inc., Northampton, MA): y = Ahigh/[1 + ([Agonist]/EC50,
high)phigh] + Alow/[1 + ([Agonist]/EC50,
low)plow], where y
is the normalized response amplitude, high and low refer to relative
agonist sensitivity, Ax is the amplitude
of that component of the fitted curve, and
px is the steepness for that component of
the fitted curve. To calculate the fractions of the nAChRs that
corresponded to the higher sensitivity population of nAChRs, the peak
currents that were measured in response to the application of 10 µM
ACh were used. This concentration was at the plateau phase of the high
sensitivity portion of the curve and minimized contributions of the
lower sensitivity population of nAChRs to the current. The response to
300 µM ACh was used to represent all functional nAChRs so that the
relative amounts of the low- and high-sensitivity population of nAChRs
could be estimated. Desensitization time constants were determined by
fitting exponential equations to the data. Representative traces were constructed by opening data files in Axograph 3.55 (Axon Instruments, Union City, CA) and exporting data to Canvas 7.0 (Deneba Software, Inc., Miami, FL).
Single-Channel Analyses.
Single-channel currents were
recorded and analyzed as described previously (Nelson and Lindstrom,
1999
). Briefly, channel activity was recorded in outside-out
configuration patches by isolating the patch in a stream of ACh
(0.05-5 µM). To allow data to be compared with data obtained using
oocyte expression (Kuryatov et al., 1997
), recordings were performed as
described previously (Nelson and Lindstrom, 1999
) in ND-96 solution
consisting of 96 mM NaCl, 2 mM KCl, 1 mM MgCl2,
1.8 mM CaCl2, and 5 mM HEPES, pH 7.6, that also
contained 50 mM dextrose. The recording electrodes were filled with a
solution consisting of 80 mM CsF, 20 mM CsCl, 10 mM Cs-EGTA, 10 mM
HEPES, and 3 mM MgATP, pH 7.2. Data were sampled off-line at 15 kHz
(Axoscope 2.0, Axon) and filtered at 3 kHz (model 902; Frequency
Devices, Inc., Haverhill, MA) for analysis. All single-channel analyses
and fitting were performed with pClamp 6.0.3 (Axon).
nAChR Isolation.
Detergent extraction of nAChRs was
performed as described previously (Nelson et al., 2001
) with slight
modification. Briefly, cells were removed from 100-mm tissue culture
dishes using 5 mM EDTA in phosphate-buffered saline (PBS) and pelleted
by centrifugation. The pellet was then suspended in 1 ml buffer A (50 mM
Na2HPO4-NaH2PO4, pH 7.5, 50 mM NaCl, 5 mM EDTA, 5 mM EGTA, 5 mM benzamidine, 15 mM
iodoacetamide, and 2 mM phenylmethylsulfonyl fluoride) and the cells
were lysed by sonication. Membrane fragments were collected by
ultracentrifugation (20 min, 100,000g) in an XL-90
ultracentrifuge with a 50.2 Ti rotor and 6.5-ml thick-walled
polycarbonate tubes with adapters (all from Beckman Coulter, Fullerton,
CA) and the pellets extracted with 0.5 ml of 2% Triton X-100 in buffer
A for 1 h at room temperature or 2 h at 4°C. The nAChR
extracts were then cleared of insoluble material by ultracentrifugation
(30 min, 170,000g). Crude extracts were subjected to
radioimmunoassays, sucrose gradient sedimentation, or direct
immunopurification. Radioimmunoassays were performed to access the
number of nAChRs in extracts, as described previously (Nelson et al.,
2001
), using [3H]epibatidine (2 nM).
Subunit Stoichiometry Using [35S]methionine
Incorporation.
For stoichiometry measurements, cells were plated
in 100-mm plates and grown under normal conditions until 80%
confluent. To metabolically label
4 and
2 subunits with
[35S]methionine, the cells were first depleted
of methionine by removing the normal tissue culture medium, followed by
a rinse with serum-free, methionine-deficient, high-glucose DMEM
(Invitrogen) and then incubated for 1 h in methionine-free medium.
After 1 h, the medium was replaced with fresh methionine-free
media (5 ml for 100 mm plate) that also contained 1 mCi
L-[35S]methionine (1175 Ci/mM;
PerkinElmer Life Sciences, Inc., Boston, MA) and 10% normal
(containing methionine) DMEM. Labeling was continued overnight under
otherwise normal conditions. To test the effect of nicotine treatment,
nicotine (0.2 µM) was added at the same time as
[35S]methionine. Control dishes without
[35S]methionine were handled in parallel. When
labeling was complete, the labeling medium was removed and the cells
were washed twice with 5 ml of ice-cold PBS and then removed from
dishes with 5 mM EDTA in PBS. Detergent extracts were prepared as
described above. Selection of fully assembled nAChRs was achieved by
sucrose gradient sedimentation as described below. Immunopurification of
4
2 nAChRs from sucrose gradient peak fractions was achieved by
incubating pooled fractions at 4°C overnight with mAb 295-(binds to
2 subunits) coupled Sepharose (30 µl of 2 mg/ml; Activated CH
Sepharose 4B resin, Amersham Biosciences AB, Uppsala, Sweden). The
resin was then collected in compact reaction columns on 90-µm filters
(United States Biochemical Corp, Cleveland, OH) and washed six times
with 400 µl of 0.5% Triton X-100/PBS. Bound nAChRs were then eluted
with 3% SDS sample buffer (75 µl) without reducing agent. SDS-PAGE
was then used to separate
4 and
2 subunits, as described below
under Western Blotting. Control and
[35S]methionine-labeled samples were run on the
same gel. The gel was divided and the
[35S]methionine-labeled side dried in 20%
glycerol (diluted in a solution of 40% methanol and 10% acetic acid),
whereas the control side was transferred to polyvinylidene difluoride
membrane for Western blotting. After autoradiography of the dried gel
using a Kodak Biomax Transcreen LE intensifying screen (Eastman Kodak, Rochester, NY), the bands corresponding to
4 or
2 subunits were cut from the gel, minced with a sharp blade, and then transferred to
scintillation tubes for measurement of incorporated
[35S]methionine activity. Because human
4
and
2 subunits contain equal numbers of methionine residues, their
relative numbers can be calculated directly from the measured
radioactivity after subtracting background (section of an unused lane
from the same gel).
Sucrose Gradients.
Total membrane extracts were prepared, as
described above with 2% Triton X-100 in buffer A, and 150 µl was
layered on 5-ml sucrose gradients (5-20%, linear) at 4°C.
Centrifugation (390,000g) was conducted for 1 h at
4°C (using rotor NVT90 in the XL-90 ultracentrifuge. Fractions from
the gradients were collected on bovine serum albumin-coated microwells
(11 drops per fraction; approximately 110 µl) using a Gilson 203 microfraction collector (Gilson Inc., Middleton, WI). nAChRs were
quantitated using radioimmune assays on mAb 295-coated wells using 10 nM [3H]epibatidine at room temperature. After
2 h, unbound material was removed from the wells followed by three
washes with ice-cold 0.5% Triton X-100 in PBS. Bound material was
eluted with 100 µl of 2% SDS that contained 2.5%
-mercaptoethanol and then subjected to scintillation counting. These
data were used to determine which four fractions from the sucrose
gradients of the [35S]methionine-labeled nAChRs
form the peak corresponding to fully assembled nAChRs that would be
used for further immunopurification. Torpedo californica
nAChRs were sedimented simultaneously on the gradients as an internal
standard. These were isolated on wells coated with mAb 210 (to
1
subunits) and labeled with 125I-
-bungarotoxin
(20 nM) overnight at 4°C. Wells were then washed three times with
ice-cold 0.5% Triton X-100 in PBS and then subjected to gamma counting.
Western Blotting.
nAChRs were eluted from mAb 295-coupled
Sepharose using 3% SDS sample buffer (75 µl) without reducing agents
with a 10-min room temperature incubation. The samples were prepared
and electrophoresed on 10% polyacrylamide gels containing SDS as
described previously (Nelson et al., 2001
). After transfer to
polyvinylidene difluoride membranes (Trans-Blot; Bio-Rad, Hercules,
CA), the blots were blocked with 5% (w/v) dried milk
(Nestlé USA, Solon, OH) in PBS with 0.05% Tween 20 and 10 mM
NaN3 (PBS/Tween), for 1 h at room temperature and then labeled overnight at 4°C with rat antisera against
4 or
2 subunits (Kuryatov et al., 2000
) at 1:200
dilutions. After three washes with PBS/Tween, labeling was done by the
addition of 125I-labeled goat anti-rat IgG
antibodies (2 nM, ~0.8 Ci/mmol) for 3 h at room temperature.
After a brief rinse and 3 washes (10 min each) with PBS/Tween,
autoradiography was performed at
80°C with exposures between 10 min
and overnight using Kodak Biomax MS film and a Biomax intensifying
screen (Eastman Kodak).
| |
Results |
|---|
|
|
|---|
Properties of Macroscopic
4
2 Currents in Permanently
Transfected HEK Cells.
HEK (tsA201) cells stably expressing human
4 and
2 subunits exhibited robust whole cell currents in response
to agonist exposure. The concentration/response relationship to various
agonists revealed a rank order of agonist potency of nicotine
1,1-dimethyl-4-phenylpiperazinium (DMPP) > ACh (Fig.
1) for the major component of the curves.
The data for both ACh and nicotine exhibited a two-component
relationship, indicating the presence of two functionally distinct
classes of agonist-nAChR interactions. DMPP exhibited a monophasic
concentration/response relationship, but a second component to the
curve could have been obscured by its reduced efficacy. The
EC50 determined for DMPP was 20 ± 2 µM,
whereas nicotine had EC50 values of 0.3 ± 0.1 and 18 ± 2 µM and ACh had EC50 values
of 0.7 ± 0.4 and 74 ± 6 µM. Cytisine's efficacy was too
low to determine its potency. For ACh, the higher sensitivity component
represented about 18 ± 2% of the nAChRs contributing to the
current. This minor population of nAChRs in the cell line
exhibited sensitivities similar to those of oocyte-expressed nAChRs
activated by ACh (2.2 ± 0.1 µM) or nicotine [0.3 ± 0.04 µM (Kuryatov et al., 1997
)]. Relative to ACh, the efficacies of the
other agonists were: nicotine, 80%; DMPP, 50%; and cytisine, ~5%.
Judging from the rebound in current amplitude upon washout of both
nicotine and DMPP, the mechanism of the partial efficacy probably was
caused by channel block by agonist. The duration of the rebound
currents during washout of high concentrations of nicotine was
particularly striking (Fig. 1D).
|
-erythroidine (Fig. 2C).
|
Single Channel Properties of
4
2 nAChRs in Permanently
Transfected HEK Cells.
Single channel recordings were performed in
the outside-out configuration using recording conditions that would
mimic those that were used previously to characterize human
4
2
nAChRs expressed in X. laevis oocytes (Fig.
3; Kuryatov et al., 1997
).
4
2
nAChRs from transfected HEK cells exhibited two channel amplitudes of 1.7 ± 0.1 and 2.3 ± 0.1 pA at
80 mV (Fig. 3). These
amplitudes were similar to those found for oocyte-expressed nAChRs
[1.4 ± 0.1 and 2.3 ± 0.1 pA at
80 mV (Kuryatov et al.,
1997
)]. The main difference observed for nAChR activity recorded from
the cell line was that the smaller amplitude channel was observed at
very low frequency regardless of agonist concentration (not shown). The
larger conductance channels appeared at sufficient levels to perform
kinetic analysis. Histograms of the mean open times revealed two
kinetic components that were best fit with double exponential functions
having mean time constants of 1.6 ± 0.2 ms and 8.5 ± 1 ms
(n = 4; Fig. 3). These values were very similar to
those obtained previously for the larger amplitude channel recorded
from oocyte-expressed
4
2 nAChRs, 1.9 ± 0.2 and 8.1 ± 0.6 ms (Kuryatov et al., 1997
). The lower conductance channel from the
cell line appeared at frequencies too low to fit in histograms, but 220 events pooled from eight patches had an arithmetic mean duration of
3.9 ± 0.5 ms. In oocytes, the lower amplitude channel had time
constants of 3.6 ± 0.5 and 23 ± 5 ms (Kuryatov et al., 1997
). The predominance of the larger conductance channel in the transfected cell line paralleled the predominance of the low
sensitivity population of nAChRs. The existence of two functional types
of nAChRs, with domination of both the macroscopic and microscopic functional data by one, raised the question of what mechanism was
responsible for the difference between the two forms.
|
Transient Transfection of the
4
2 Cell Line with Additional
2 cDNA Increased the Proportion of nAChRs that Exhibited High
Agonist Sensitivity.
The existence of the higher sensitivity
component in the concentration/response studies validates the
capability of the HEK cells to assemble and/or process the mature
protein `properly', but their scarcity indicates that HEK cells are
predisposed to express an alternate form of
4
2 nAChRs. Such an
alternate form could result from different possible mechanisms (e.g.,
1) nAChRs formed in HEK cells are differentially modified
post-translationally or 2) HEK cells can assemble nAChRs with different
subunit stoichiometries. There is precedent for both of these
mechanisms to affect the functional properties of nicotinic AChRs.
Various studies have reported that phosphorylation alters the
functional properties of nAChRs (Huganir et al., 1986
; Margiotta et
al., 1987
; Fenster et al., 1999
). Alternatively, one study suggested
that different functional properties of
4
2 nAChRs might be
attributed to different subunit stoichiometries (Zwart and Vijverberg,
1998
). In this case, the functional properties correlated with the
particular ratio of
4:
2 subunit cDNAs that were expressed. When
the
:
ratio was high, the resulting nAChRs had low agonist
sensitivity and exhibited significant desensitization at saturating
concentrations of agonist. Alternately, when the
4/
2 cDNA ratio
was lower, the resulting nAChRs exhibited higher sensitivity to
activation by agonist and desensitized little at saturating agonist
concentrations. To investigate the molecular explanation for the
existence of two functionally distinct populations of
4
2 nAChRs
in the permanently transfected HEK cells, we designed several
experiments that attempted to alter the functional properties of the
nAChRs expressed by permanently transfected HEK cells. Because the
functional properties of the majority of the nAChRs expressed by the
4
2 cell line resembled the properties of high
/
nAChR
subunit ratios expressed in oocytes, we considered that the HEK cells
were also expressing a high
/
subunit ratio, even though they
were transfected with equal amounts of cDNA. For example, unassembled
2 subunits might be degraded more rapidly than unassembled
4
subunits. This might result in formation of nAChRs with more
than
subunits. Alternatively,
4 subunits might be assembled
preferentially into mature nAChRs. In either case, increased expression
of
2 subunit might alter the stoichiometry. To test this hypothesis,
we transiently transfected our stable
4
2 cell line with
additional
2 subunit cDNA to further promote the production of
2
protein. The rationale was based on the observation that expression of
exogenous proteins is higher within days after transfection and falls
during subsequent cloning of permanently transfected cells. The result
of transient transfections of permanently transfected
4
2 cells
with more
2 cDNA was an increase in the higher sensitivity component
of the concentration/response relationship (Fig.
4) to about 43 ± 4% of the total
population of nAChRs. The EC50 values were 2 ± 0.4 and 90 ± 17 µM. This result is consistent with the idea
that increased expression of
2 protein resulted in its increased
assembly into new nAChRs, which were more sensitive to activation by
ACh (i.e., nAChR
4/
2 stoichiometry preference was shifted).
|
2 subunit after transfection, the
4
2 cell line was transiently transfected with
4.
4 was chosen because it was an obvious substitute for
2 and because
4
4 nAChRs have been shown to desensitize significantly more slowly than
4
2 nAChRs, allowing for unambiguous detection of its
incorporation (e.g., Chavez-Noriega et al., 1997
4 transfection, the currents exhibited slower activation and less desensitization than naive
4
2 cells or
2-transfected
4
2
cells (Fig. 4). The concentration/response relationship for ACh on
4-containing nAChRs revealed a three-component curve that reflected
a complex mixture of nAChRs. The EC50 values were
0.1 ± 0.04, 3 ± 0.4, and 84 ± 20 µM. Thus,
additional, transient transfection of the stable
4
2 cell line
with either
2 or
4 subunit cDNA resulted in nAChRs that reflect
incorporation of the additional subunit.
Long-term Treatment with Nicotine or Culture at 29°C Increased
the Relative Proportion of nAChRs That Had Higher Agonist
Sensitivity.
Recently, it was reported that long-term
exposure of
4
2 expressing HEK cells to low concentrations of
nicotine increased the higher sensitivity fraction of nAChRs (Buisson
and Bertrand, 2001
). We tested this effect of nicotine on our
4
2
cell line to compare it with that of overexpression of
2 subunit.
The cells were incubated overnight with nicotine (0.5 or 5 µM) and
then tested for their sensitivity to activation by ACh. In agreement with Buisson and Bertrand (2001)
, overnight treatment with
nicotine increased the population of the nAChRs more sensitive to
activation by ACh to about 32 ± 5% of the total. The
EC50 values were 0.6 ± 0.4 µM and 84 ± 9 µM (Fig. 5). The effect of
nicotine on these cells was similar to the result of transient
transfection with additional
2 subunit. The similarity in effect
between these two treatments suggested that both led to increased
production of nAChRs with higher
2 content and that these nAChRs
exhibited higher sensitivity to activation.
|
4
2 nAChRs was investigated also. Surprisingly, nicotine treatment
reduced the complexity of channel activity recorded from these cells.
The appearance of the lower conductance channel was infrequent (Fig.
6) but when present, it exhibited the
same amplitude as the naive nAChRs. Additionally, the gating kinetics were more uniform, with open duration distributions that reflected a
single kinetic species with a mean time constant of 2.2 ± 0.1 ms
(n = 7; one patch required an additional time constant
of 12 ms). One explanation for the channel behavior after nicotine
treatment could be that the more sensitive nAChRs (i.e., lower
conductance channels) are more susceptible to the phenomenon of rundown
after long-term exposure to nicotine.
|
4
2 nAChRs. The effect of this
treatment was much the same as both transiently transfecting the
4
2 cells with additional
2 subunit or overnight exposure to
nicotine. The cells had a larger fraction of nAChRs that exhibited greater sensitivity to activation by ACh. The
EC50 values were 1.7 ± 0.3 µM and 58 ± 4 µM, accounting for 34 ± 6% and 67 ± 6% of the
distribution, respectively. Thus, overnight culture at reduced
temperature seems to favor formation of nAChRs that consist of more
subunits than nAChRs formed under normal culture conditions. This
temperature-dependent effect might reflect reduced destruction of
unassembled
2 subunits and/or increased assembly of
2 with
4
subunits. Because the standard protocol for X. laevis
oocytes is to maintain them at 16 to 19°C, oocytes that are injected
with equal amounts of
4 and
2 cDNAs or cRNAs would, presumably,
tend to assemble nAChRs in a manner more like the HEK cells that were incubated overnight at 29°C. This also might explain the requirement for the high
4/
2 injection ratios that are needed to form
recombinant nAChRs with low sensitivity to activation (Zwart and
Vijverberg, 1998Most
4
2 nAChRs Expressed in Permanently Transfected HEK Cells
Have an (
4)3(
2)2 Subunit
Stoichiometry.
Although the preceding experiments were consistent
with the existence of two nAChR stoichiometries that have different
functional properties, they were not definitive. As final confirmation,
a direct measure of the number of
and
subunits present in
assembled nAChRs was necessary. We chose to perform these measurements
using an approach similar to that used to establish the subunit
stoichiometry of chick
4
2 nAChRs (Anand et al., 1991
). This was
achieved by metabolically labeling the proteins in the
4
2 cell
line with [35S]methionine and then selecting
for fully assembled nAChRs using sucrose gradient sedimentation. Fully
assembled nAChRs were then collected from the gradients and purified
further using mAb 295 (to the
2 subunit) coupled to Sepharose beads.
Immunopurified nAChRs were denatured into individual subunit proteins
and then resolved by SDS-PAGE. After autoradiography of the dried gel, the bands corresponding to
4 and
2 subunits were cut from the gels and the amount of [35S]methionine in each
subunit was determined by liquid scintillation counting
(Fig. 8). Because human
4 and
2
subunits have the same number of methionine residues, the relative
amount of each subunit was determined by direct comparison of the
measured activity after subtraction of background. For
4
2 cells
that were grown under normal conditions, the
4/
2 subunit ratio of
fully assembled nAChRs was 1.5:1 (Table
1). Addition of nicotine (0.2 µM) along with [35S]methionine increased the amount of
[35S]methionine that was incorporated into
newly assembled nAChRs compared with untreated cells. This was similar
to the increase in [3H]epibatidine binding
measured by radioimmunoassays for cells handled in parallel: binding
increased 3.8-fold (from 1258 ± 81 fmol/mg of protein to
4790 ± 548 fmol/mg of protein) after nicotine (0.2 µM)
incubation. Nicotine incubation also shifted the ratio of
4/
2
subunits to 1:1, seemingly reflecting a nearly even mixture of the two
populations of nAChRs after nicotine treatment. These results
illustrated three important points: 1) in HEK cells, the predominant
nAChRs formed had an
(
4)3(
2)2
stoichiometry, 2) long-term nicotine treatment increased the number of
nAChRs measured in terms of both assembled protein and ligand binding,
and 3) nicotine treatment lowered
4/
2 ratio in fully assembled
nAChRs, consistent with an increase in the proportion of those with
(
4)2(
2)3 stoichiometry. These findings paralleled the functional studies that
showed the existence of a dual population of nAChRs. If for the
functional studies, the more sensitive nAChR is assumed to be
(
4)2(
2)3, and the
less sensitive nAChR is
(
4)3(
2)2, the
/
ratio predicted from the relative contributions of each species to the
total current would be 1.4 for control and 1.2 for nicotine-treated cells. From the [35S]methionine incorporation
measurements (Table 1), the average
/
ratios were 1.5 and 1.0, respectively. The control values compared well between the two
measurements, but the nicotine-treated values were less similar. The
discrepancy in the value for nicotine-treated cells probably arose from
the fact that functional nAChRs included pre-existing nAChRs as well as
those formed during nicotine exposure, whereas metabolic labeling
measured only nAChRs formed in the presence of nicotine. Thus the
/
ratio calculated from the functional studies overestimated the
(
4)3(
2)2 levels after
nicotine treatment. Both functional and biochemical measures indicated
that cells normally produced predominantly an
(
4)3(
2)2 nAChR, which
was less sensitive to activation, whereas long-term exposure to
nicotine favored formation of the
(
4)2(
2)3 nAChR, which
was more sensitive.
|
|
|
| |
Discussion |
|---|
|
|
|---|
We have found that human
4
2 nAChRs in an HEK cell line
coexist in two functional forms. The minority of the nAChRs exhibited properties that resembled nAChRs expressed in X. laevis
oocytes (Kuryatov et al., 1997
), whereas the majority were considerably less sensitive to activation and desensitized more quickly. Similar findings were reported for another human
4
2 cell line (Buisson and Bertrand, 2001
). More significantly, we found that
4
2 nAChRs in the cell line preferentially exist in a
(
4)3(
2)2
stoichiometry. By increasing the amount of
2 subunit, by incubation
time in nicotine, or by culture at reduced temperature, the magnitude of the minority fraction of functional nAChRs was increased. The properties of this fraction of nAChRs resembled those of
4
2 nAChRs in X. laevis oocytes (Kuryatov et al., 1997
).
4
2 nAChRs with these properties, were shown to have an
(
4)2(
2)3
stoichiometry (Anand et al., 1991
; Cooper et al., 1991
; Whiting et al.,
1991
). Thus, human
4
2 nAChRs assemble with two different
stoichiometries, each exhibiting distinct functional properties. The
fraction of (
4)2(
2)3
stoichiometry formed was increased by factors that promoted the
availability of
2 subunit for assembly.
Electrophysiological studies have been reported on several stably
transfected HEK cell lines expressing rat and human
4
2 nAChRs
(Sabey et al., 1999
; Buisson et al., 2000
; Chavez-Noriega et al.,
2000
). In all cases, the predominant nAChRs exhibited low sensitivity
to activation by ACh. In oocytes, it was reported that
4
2 nAChRs
could be manipulated to express high- and low-sensitivity forms by
varying the relative amounts of each subunit (Zwart and Vijverberg,
1998
). It was suggested that nAChR stoichiometry was altered, but no
direct evidence was provided. Our
4
2 cell line exhibited
properties that were remarkably similar to those reported for
4
2
nAChRs formed from 9
/1
subunit ratios. By direct measurement, we
have found that the preponderance of the less sensitive form of
4
2 nAChRs corresponds to a novel
(
4)3(
2)2
stoichiometry in stably transfected HEK cells.
Buisson and Bertrand (2001)
reported that an increase in the fraction
of high-sensitivity
4
2 nAChRs occurred after incubating transfected cells in nicotine. They speculated that the shift was
caused by isomerization between existing pools of surface nAChRs
(Buisson and Bertrand, 2001
). Such a mechanism does not account for
nicotine-induced increases in nAChR numbers observed in cell culture
and in brain (Benwell et al., 1988
; Wonnacott, 1990
; Marks et al.,
1992
; Peng et al., 1994
; Gopalakrishnan et al., 1996
; Whiteaker et al.,
1998
). It has been well documented that nicotine-induced up-regulation
of nAChRs occurs independently of protein synthesis (Peng et al., 1994
;
Wang et al., 1998
) and that up-regulation results from increased
assembly (Wang et al., 1998
) in combination with reduced turnover of
existing surface nAChRs (Peng et al., 1994
). Nicotine-induced change in
stoichiometry is compatible with these observations. Additionally,
different stoichiometries are more likely to account for different
conductance properties of each nAChR type that we and others (Buisson
and Bertrand, 2001
) observed, because the change in subunit composition would change the amino acid residues lining the lumen of the channel. Our data showed that the larger conductance, shorter gating channel correlated better with the less sensitive nAChR form, because it was
the predominant channel type observed in patches from our
4
2 cell
line. This was opposite the conclusion of Buisson and Bertrand (2001)
.
By our account, nAChRs that contained three
4 subunits had higher
conductance than those with three
2 subunits. This observation
correlated nicely with the single channel study that helped to
establish the
(
4)2(
2)3
stoichiometry for chick nAChRs (Cooper et al., 1991
). The channel
forming M2 transmembrane regions of human and chick
4 and
2
subunits are identical. Single channel currents for chick
4
2
nAChRs [with the
(
4)2(
2)3
stoichiometry] had a homogeneous population of channels with a
conductance [20 pS (Cooper et al., 1991
)] that was similar to the
lower conductance infrequently observed from our cell line (21-pS chord
conductance). A residue that differed between
4 and
2 in the
channel region was found to alter channel conductance. When this
residue was mutated in
2 to match the residue at the same position
in
4, the channel conductance increased. When mutant nAChRs
contained three `
4-like' residues, the channel chord conductance
was 27 pS (Cooper et al., 1991
). In our
4
2 cell line, the
predominant channel type had a chord conductance of 29 pS that
reflected three `
4-like' residues in
(
4)3(
2)2 nAChRs.
Three other residues differ in M2 between
4 and
2, but
2 to
4 substitutions would probably not alter channel conductance at
these positions (Karlin and Akabas, 1995
). The similarities between
human and chick nAChR channel conductances provided evidence to support
our belief that the larger conductance channel was the
(
4)3(
2)2 nAChR that
had low sensitivity to activation.
Consider the possibility that in brain, each of the
4
2 nAChR
stoichiometries might serve a different functional role. Muscle nAChRs
provide an example of different nAChR subunit compositions serving
different functional roles. With innervation at the neuromuscular junction, the functional properties of nAChRs are changed by a switch
from nAChRs that contain
subunits to those that contain
subunits (Sanes and Lichtman, 2001
). Nonjunctional nAChRs in immature
muscle exist at low density and are optimized to respond to diffuse
transmitter release with long channel openings during development.
Postsynaptic nAChRs in mature muscle are optimized to respond to high
ACh concentrations with relatively low affinity and brief channel
openings to accurately transmit rapid impulse patterns. In the brain,
most
4
2 nAChRs act presynaptically or preterminally to modulate
transmitter release (Wonnacott, 1997
). In some cases, this modulation
might occur by `volume transmission,' whereby diffusion of
transmitter from adjacent synapses activates these nAChRs (Zoli et al.,
1999
). In such cases, more sensitive (
4)2(
2)3 nAChRs would
better serve such a role. However, where
4
2 nAChRs serve a
traditional postsynaptic role in which complex signals must be rapidly
and faithfully transmitted, less sensitive (
4)3(
2)2 nAChRs would
be optimal.
Long-term nicotine exposure favors formation of more sensitive
4
2
nAChRs. By increasing both nAChR numbers and their sensitivity to
activation, the response to ACh and nicotine should be increased. These
changes could reflect a form of plasticity that is activated in
response to the desensitizing effects of nicotine in an attempt to
normalize nicotinic signaling. Because over-expression of
2 causes a
shift in functional properties that resembles the effect of nicotine,
this subunit might be key to the process.
2 might be disfavored from
assembling with intermediates perhaps through limiting its availability
by targeted degradation.
4-
2 dimers must form to create
agonist-binding sites. These might assemble into
4
2
4
2
tetramers. At this point, the fifth subunit to assemble would occupy
the position analogous to the
1 position of muscle-type nAChRs. The
subunit at this position does not contribute to an agonist binding site
or change nAChR ligand binding affinity, but influences gating kinetics
and channel conductance (Gerzanich et al., 1998
). When
2 subunit is
limiting, we propose that
4 assembles in this position to produce
the (
4)3(
2)2
pentamer. With sufficient
2 subunit present, as when additional
subunit was transiently transfected, we propose that more
2
assembles to complete the
(
4)2(
2)3 pentamer in
this position. This position might be occupied by
5, as in 26% of
rat brain nAChRs (Gerzanich et al., 1998
), suggesting that changes in
both nAChR composition and stoichiometry at this site can be used to
regulate
4
2 nAChR function. Long-term exposure of the nAChR to
nicotine or culturing at 29°C acts to shift the relative amounts of
each population of nAChRs, also. These conditions might provide a
signal to reduce constitutive degradation of
2 subunits.
Constitutive degradation of muscle nAChR
1 subunits has been
demonstrated in which most are degraded before assembly (Merlie and
Lindstrom, 1983
). Another trafficking molecule might also be involved
that shields or exposes subunit regions that are important in assembly.
What are the implications of these finding on long-term exposure of
4
2 nAChRs to nicotine in the brain? It is well known that
exposure to nicotine (at concentrations that are readily achieved by
smokers) causes the number of nAChRs in brain to increase (Benwell et
al., 1988
; Wonnacott, 1990
; Marks et al., 1992
). Here, we show that
nicotine exposure also favors the formation of nAChRs with increased
sensitivity because of a stoichiometry with higher
2 content. In
cells coexpressing
2 and
4 containing nAChRs (IMR-32 and
SH-SY5Y), nicotine-induced up-regulation can be directly attributed to
an increase in
2-containing nAChRs (Wang et al., 1998
; Nelson et
al., 2001
). In HEK cells expressing
3
2 nAChRs, limited numbers of
nAChRs are expressed on the surface, but culturing in nicotine or at
29°C results in large numbers of surface nAChR (Nelson et al., 2001
).
All of these observations implicate tight regulation of the
2
subunit in nAChR expression. An additional signal might be required for
2 to be made available to associate with nAChR assembly
intermediates. Its identity and any other players involved in the
process remain to be determined. Because nicotine influences this
process, the control of stoichiometric preference could be important in addiction.
| |
Acknowledgments |
|---|
We thank Ben McNeil, Dipali Sahoo, and John Cooper for valued technical assistance.
| |
Footnotes |
|---|
Received July 30, 2002; Accepted October 30, 2002
This work supported by grant NS11323 from the National Institutes of Health and the Smokeless Tobacco Research Council (to J.L.).
Address correspondence to: Dr. Jon Lindstrom, 217 Stemmler Hall, Medical School of the University of Pennsylvania, Philadelphia, PA 19104-6074. E-mail: jslkk{at}mail.med.upenn.edu
| |
Abbreviations |
|---|
nAChR, nicotinic acetylcholine receptor; HEK, human embryonic kidney; mAb, monoclonal antibody; PBS, phosphate-buffered saline; DMEM, Dulbecco's modified Eagle's medium; PAGE, polyacrylamide gel electrophoresis; DMPP, 1,1-dimethyl-4-phenylpiperazinium.
| |
References |
|---|
|
|
|---|
)-[3H]nicotine binding sites in human brain.
J Neurochem
50:
1243-1247[Medline].
4
2 nicotinic acetylcholine receptor function.
J Neurosci
21:
1819-1829
4
2 nicotinic acetylcholine receptor.
Neuropharmacol
39:
2561-2569[CrossRef][Medline].
2
2, h
2
4, h
3
2, h
3
4, h
4
2, h
4
4 and h
7 expressed in Xenopus oocytes.
J Pharmacol Exp Ther
280:
346-356
3
2 and
4
2 stably expressed in HEK293 cells.
Neuropharmacol.
39:
2543-2560[CrossRef][Medline].
4
2 neuronal nicotinic receptors by lower temperature and expression of chimeric subunits.
J Biol Chem
274:
27145-52
4
2 nicotinic receptor desensitization by calcium and protein kinase C.
Mol Pharmacol
55:
432-443
5 subunit alters desensitization, pharmacology, Ca2+ permeability and Ca2+ modulation of human neuronal
3 nicotinic receptors.
J Pharmacol Exp Ther
286:
311-320
4
2 receptor.
J Pharmacol Exp Ther
276:
289-297
4
2 nicotinic acetylcholine receptors.
J Neurosci
17:
9035-9047
2 subunit.
J Pharmacol Exp Ther
289:
1090-1103
3 AChRs: impact of
2,
4 and
5 subunits.
J Physiol (Lond)
516:
657-678
3
4 AChRs expressed in permanently transfected HEK cells.
J Gen Physiol
118:
563-582
2 subunit.
Mol Pharmacol
45:
142-149[Abstract].
2 subunit are involved in the reinforcing properties of nicotine.
Nature (Lond)
391:
173-177[CrossRef][Medline].
4
2 receptors stably expressed in HEK293 cells.
Mol Pharmacol
55:
58-66
3
2, but not
3
4 AChRs stably transfected in human embryonic kidney cells.
J Biol Chem
273:
28721-28732
4
2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Mol Pharmacol
53:
950-962
4
2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.
Mol Pharmacol
54:
1124-1131This article has been cited by other articles:
![]() |
C. D. Son, F. J. Moss, B. N. Cohen, and H. A. Lester Nicotine Normalizes Intracellular Subunit Stoichiometry of Nicotinic Receptors Carrying Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Mol. Pharmacol., May 1, 2009; 75(5): 1137 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Falvella, A. Galvan, E. Frullanti, M. Spinola, E. Calabro, A. Carbone, M. Incarbone, L. Santambrogio, U. Pastorino, and T. A. Dragani Transcription Deregulation at the 15q25 Locus in Association with Lung Adenocarcinoma Risk Clin. Cancer Res., March 1, 2009; 15(5): 1837 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function Physiol Rev, January 1, 2009; 89(1): 73 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation J. Neurosci., July 2, 2008; 28(27): 6884 - 6894. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuryatov, J. Onksen, and J. Lindstrom Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zwart, A. L. Carbone, M. Moroni, I. Bermudez, A. J. Mogg, E. A. Folly, L. M. Broad, A. C. Williams, D. Zhang, C. Ding, et al. Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant {alpha}4{beta}2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., June 1, 2008; 73(6): 1838 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Barrera, J. Betts, H. You, R. M. Henderson, I. L. Martin, S. M. J. Dunn, and J. M. Edwardson Atomic Force Microscopy Reveals the Stoichiometry and Subunit Arrangement of the {alpha}4{beta}3{delta} GABAA Receptor Mol. Pharmacol., March 1, 2008; 73(3): 960 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C.-l. Lam, L. Girard, R. Ramirez, W.-s. Chau, W.-s. Suen, S. Sheridan, V. P.C. Tin, L.-p. Chung, M. P. Wong, J. W. Shay, et al. Expression of Nicotinic Acetylcholine Receptor Subunit Genes in Non-Small-Cell Lung Cancer Reveals Differences between Smokers and Nonsmokers Cancer Res., May 15, 2007; 67(10): 4638 - 4647. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tapia, A. Kuryatov, and J. Lindstrom Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors Mol. Pharmacol., March 1, 2007; 71(3): 769 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kishi and J. H. Steinbach Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic {alpha}4beta2 Receptors Mol. Pharmacol., December 1, 2006; 70(6): 2037 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Broadbent, P. J. Groot-Kormelink, P. A. Krashia, P. C. Harkness, N. S. Millar, M. Beato, and L. G. Sivilotti Incorporation of the beta3 Subunit Has a Dominant-Negative Effect on the Function of Recombinant Central-Type Neuronal Nicotinic Receptors Mol. Pharmacol., October 1, 2006; 70(4): 1350 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moroni, R. Zwart, E. Sher, B. K. Cassels, and I. Bermudez {alpha}4beta2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine Mol. Pharmacol., August 1, 2006; 70(2): 755 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Briggs, E. J. Gubbins, M. J. Marks, C. B. Putman, R. Thimmapaya, M. D. Meyer, and C. S. Surowy Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of {alpha}4beta2 and {alpha}3beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., July 1, 2006; 70(1): 227 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Groot-Kormelink, S. Broadbent, M. Beato, and L. G. Sivilotti Constraining the Expression of Nicotinic Acetylcholine Receptors by Using Pentameric Constructs Mol. Pharmacol., February 1, 2006; 69(2): 558 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. White Pretty Subunits All in a Row: Using Concatenated Subunit Constructs to Force the Expression of Receptors with Defined Subunit Stoichiometry and Spatial Arrangement Mol. Pharmacol., February 1, 2006; 69(2): 407 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Person, K. L. Bills, H. Liu, S. K. Botting, J. Lindstrom, and G. B. Wells Extracellular Domain Nicotinic Acetylcholine Receptors Formed by {alpha}4 and {beta}2 Subunits J. Biol. Chem., December 2, 2005; 280(48): 39990 - 40002. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors Mol. Pharmacol., December 1, 2005; 68(6): 1839 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Plazas, E. Katz, M. E. Gomez-Casati, C. Bouzat, and A. B. Elgoyhen Stoichiometry of the {alpha}9{alpha}10 Nicotinic Cholinergic Receptor J. Neurosci., November 23, 2005; 25(47): 10905 - 10912. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gotti, M. Moretti, A. Zanardi, A. Gaimarri, N. Champtiaux, J.-P. Changeux, P. Whiteaker, M. J. Marks, F. Clementi, and M. Zoli Heterogeneity and Selective Targeting of Neuronal Nicotinic Acetylcholine Receptor (nAChR) Subtypes Expressed on Retinal Afferents of the Superior Colliculus and Lateral Geniculate Nucleus: Identification of a New Native nAChR Subtype {alpha}3{beta}2({alpha}5 or {beta}3) Enriched in Retinocollicular Afferents Mol. Pharmacol., October 1, 2005; 68(4): 1162 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O. Rodrigues-Pinguet, T. J. Pinguet, A. Figl, H. A. Lester, and B. N. Cohen Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Affect Allosteric Ca2+ Activation of the {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Mol. Pharmacol., August 1, 2005; 68(2): 487 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ben-Ami, L. Yassin, H. Farah, A. Michaeli, M. Eshel, and M. Treinin RIC-3 Affects Properties and Quantity of Nicotinic Acetylcholine Receptors via a Mechanism That Does Not Require the Coiled-coil Domains J. Biol. Chem., July 29, 2005; 280(30): 28053 - 28060. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Khakh, J. A. Fisher, R. Nashmi, D. N. Bowser, and H. A. Lester An Angstrom Scale Interaction between Plasma Membrane ATP-Gated P2X2 and {alpha}4{beta}2 Nicotinic Channels Measured with Fluorescence Resonance Energy Transfer and Total Internal Reflection Fluorescence Microscopy J. Neurosci., July 20, 2005; 25(29): 6911 - 6920. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Ren, S.-B. Cheng, M. W. Treuil, J. Mukherjee, J. Rao, K. H. Braunewell, J. M. Lindstrom, and R. Anand Structural Determinants of {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Trafficking J. Neurosci., July 13, 2005; 25(28): 6676 - 6686. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. F. Vallejo, B. Buisson, D. Bertrand, and W. N. Green Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism J. Neurosci., June 8, 2005; 25(23): 5563 - 5572. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsuneki, Y. You, N. Toyooka, S. Kagawa, S. Kobayashi, T. Sasaoka, H. Nemoto, I. Kimura, and J. A. Dani Alkaloids Indolizidine 235B', Quinolizidine 1-epi-207I, and the Tricyclic 205B are Potent and Selective Noncompetitive Inhibitors of Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2004; 66(4): 1061 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Lopez-Hernandez, J. Sanchez-Padilla, A. Ortiz-Acevedo, J. Lizardi-Ortiz, J. Salas-Vincenty, L. V. Rojas, and J. A. Lasalde-Dominicci Nicotine-induced Up-regulation and Desensitization of {alpha}4{beta}2 Neuronal Nicotinic Receptors Depend on Subunit Ratio J. Biol. Chem., September 3, 2004; 279(36): 38007 - 38015. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Abdrakhmanova, L. Cleemann, J. Lindstrom, and M. Morad Differential Modulation of {beta}2 and {beta}4 Subunits of Human Neuronal Nicotinic Acetylcholine Receptors by Acidification Mol. Pharmacol., August 1, 2004; 66(2): 347 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Groot-Kormelink, S. D. Broadbent, J. P. Boorman, and L. G. Sivilotti Incomplete Incorporation of Tandem Subunits in Recombinant Neuronal Nicotinic Receptors J. Gen. Physiol., June 1, 2004; 123(6): 697 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sallette, S. Bohler, P. Benoit, M. Soudant, S. Pons, N. Le Novere, J.-P. Changeux, and P. J. Corringer An Extracellular Protein Microdomain Controls Up-regulation of Neuronal Nicotinic Acetylcholine Receptors by Nicotine J. Biol. Chem., April 30, 2004; 279(18): 18767 - 18775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nashmi, M. E. Dickinson, S. McKinney, M. Jareb, C. Labarca, S. E. Fraser, and H. A. Lester Assembly of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors Assessed with Functional Fluorescently Labeled Subunits: Effects of Localization, Trafficking, and Nicotine-Induced Upregulation in Clonal Mammalian Cells and in Cultured Midbrain Neurons J. Neurosci., December 17, 2003; 23(37): 11554 - 11567. [Abstract] [Full Text] [PDF] |
||||
![]() |
K G Paradiso and J. H. Steinbach Nicotine is highly effective at producing desensitization of rat {alpha}4{beta}2 neuronal nicotinic receptors J. Physiol., December 15, 2003; 553(3): 857 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Nguyen, B. A. Rasmussen, and D. C. Perry Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1090 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, M. E. Nelson, A. Kuryatov, C. Choi, J. Cooper, and J. Lindstrom Human {alpha}4{beta}2 Acetylcholine Receptors Formed from Linked Subunits J. Neurosci., October 8, 2003; 23(27): 9004 - 9015. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||